abstract |
The invention provides new heterocyclic compounds having the general formula (I) wherein A, L, X, m, n, R 1 and R 2 are as described herein, compositions including the compounds, processes of manufacturing the compounds, methods of using the compounds and methods of determining the monoacylglycerol lipase (MAGL) inhibitory activity of the compounds. |